home *** CD-ROM | disk | FTP | other *** search
/ Cancer - Principles & Practice of Oncology / Oncology.iso / PPO / CHAP45 / T2_8.CAP < prev    next >
Encoding:
Text File  |  1999-06-07  |  721 b   |  13 lines
  1. TABLE 45.2-8. Representative  Treatment Regimens in  Acute Myelogenous
  2. Leukemia
  3.  
  4. D, daunorubicin;  A,  cytarabine; T,  6-thioguanine; HiDAC,  high-dose
  5. cytarabine; P,  prednisone; VCR, vincristine; AMSA,  amsacrine; VP-16,
  6. etoposide; IDR,  idarubicin; mito, mitoxantrone;  allo-BMT, allogeneic
  7. bone  marrow transplantation; ATRA,  all trans retinoic  acid; GM-CSF,
  8. granulocyte-macrophage      colony-stimulating      factor;      IDAC,
  9. intermediate-dose cytarabine; CR,  complete remission; EFS, event-free
  10. survival; DFS, disease-free survival; CALGB, Cancer and Leukemia Group
  11. B; ECOG, Eastern Cooperative Oncology Group; ALSG, Australian Leukemia
  12. Study Group; MSKCC, Memorial Sloan-Kettering Cancer Center.
  13.